Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 2451 - 2475 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▲ Formula
Gangliosides LMSP0601DL08
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • sialyl-Lea(d18:1/26:1(17Z))
44262643 1802.044122 C87H155N3O35
Gangliosides LMSP0601DS08
  • Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262699 1802.044122 C87H155N3O35
Gangliosides LMSP0601EE08
  • NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • sialyl-Lex(d18:1/26:1(17Z))
44262787 1802.044122 C87H155N3O35
Diacylglycerophosphoinositolglycans LMGP15010269
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(18:2(9Z,12Z)/16:2(9Z,12Z))
126457637 1802.811483 C79H135O43P
Gangliosides LMSP0601BD06
  • Fuc-GM1(d18:1/26:0)
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262201 1804.059772 C87H157N3O35
Gangliosides LMSP0601CH06
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Sialyl-Lea(d18:1/26:0)
44262433 1804.059772 C87H157N3O35
Gangliosides LMSP0601DL06
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • sialyl-Lea(d18:1/26:0)
44262641 1804.059772 C87H157N3O35
Gangliosides LMSP0601DS06
  • Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262697 1804.059772 C87H157N3O35
Gangliosides LMSP0601EE06
  • NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • sialyl-Lex(d18:1/26:0)
44262785 1804.059772 C87H157N3O35
Diacylglycerophosphoinositolglycans LMGP15010263
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(18:1(9Z)/16:2(9Z,12Z))
126457631 1804.827133 C79H137O43P
Diacylglycerophosphoinositolglycans LMGP15010268
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(18:2(9Z,12Z)/16:1(9Z))
126457636 1804.827133 C79H137O43P
Gangliosides LMSP0601BK02
  • 9-OAc-NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262253 1804.945866 C83H144N4O38
Gangliosides LMSP0601AZ04
  • GalNAc-GM1b(d18:1/22:0)
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262167 1805.018636 C85H152N4O36
Gangliosides LMSP0601BC04
  • GalNAc-GM1(d18:1/22:0)
  • GalNAcbeta1-4Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262191 1805.018636 C85H152N4O36
Gangliosides LMSP0601BS04
  • GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262319 1805.018636 C85H152N4O36
Gangliosides LMSP0601CO04
  • GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262479 1805.018636 C85H152N4O36
Gangliosides LMSP0601CW04
  • NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262543 1805.018636 C85H152N4O36
Gangliosides LMSP0601DP04
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262671 1805.018636 C85H152N4O36
Gangliosides LMSP0601FD04
  • NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262967 1805.018636 C85H152N4O36
Gangliosides LMSP0601FI04
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44263007 1805.018636 C85H152N4O36
Gangliosides LMSP0601FX04
  • NeuAcalpha2-3GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44263111 1805.018636 C85H152N4O36
Gangliosides LMSP0601AF07
  • NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262010 1806.002652 C85H151N3O37
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AH04
  • Aleb(d18:1/22:0)
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260671 1806.039037 C86H155N3O36
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AS04
  • Fucalpha1-3GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260759 1806.039037 C86H155N3O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BM04
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261279 1806.039037 C86H155N3O36

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024